title: [Invasive cardiology: focus on restenosis. Part II].
abstract: In-stent restenosis represents a pathological process which histology is different from that of restenosis after balloon angioplasty. In-stent restenosis is mainly caused by neointima proliferation. This part of review deals with technologies of prevention of in-stent restenosis including novel stent designs and coatings aimed at suppression of neointima proliferation.
authors.forename: Iu N
authors.initials: IuN
authors.lastname: Belenkov
authors.forename: T A
authors.initials: TA
authors.lastname: Batyraliev
authors.forename: I V
authors.initials: IV
authors.lastname: Pershukov
authors.forename: A N
authors.initials: AN
authors.lastname: Samko
mesh_terms: D020533:Angiogenesis Inhibitors / Q000627:therapeutic use; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D000975:Antioxidants / Q000627:therapeutic use; D006348:Cardiac Surgical Procedures; D023903:Coronary Restenosis / Q000188:drug therapy / Q000503:physiopathology / Q000601:surgery; D006801:Humans; D011341:Probucol / Q000627:therapeutic use; D015607:Stents
chemical_list: D020533:Angiogenesis Inhibitors; D000893:Anti-Inflammatory Agents; D000975:Antioxidants; D011341:Probucol